Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.

Henning RJ, Bourgeois M, Harbison RD.

Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2. Review.

PMID:
29968072
2.

Evaluation of airborne asbestos exposure from routine handling of asbestos-containing wire gauze pads in the research laboratory.

Garcia E, Newfang D, Coyle JP, Blake CL, Spencer JW, Burrelli LG, Johnson GT, Harbison RD.

Regul Toxicol Pharmacol. 2018 Jul;96:135-141. doi: 10.1016/j.yrtph.2018.04.020. Epub 2018 Apr 30.

PMID:
29723551
3.

Reduced oxygen tension culturing conditionally alters toxicogenic response of differentiated H9c2 cardiomyoblasts to acrolein.

Coyle JP, Rinaldi RJ, Johnson GT, Bourgeois MM, McCluskey JD, Harbison RD.

Toxicol Mech Methods. 2018 Sep;28(7):488-498. doi: 10.1080/15376516.2018.1455785. Epub 2018 Jun 7.

PMID:
29564938
4.

Acrolein measurement and degradation in Dulbecco's Modified Eagle Medium: an examination of in-vitro exposure metrics.

Coyle JP, Rinaldi RJ, Johnson GT, Bourgeois MM, McCluskey J, Harbison RD.

Toxicol Mech Methods. 2018 Feb;28(2):115-121. doi: 10.1080/15376516.2017.1370755. Epub 2017 Sep 7.

PMID:
28826359
5.

Cardio-oncology: cardiovascular complications of cancer therapy.

Henning RJ, Harbison RD.

Future Cardiol. 2017 Jul;13(4):379-396. doi: 10.2217/fca-2016-0081. Epub 2017 Jun 29. Review.

PMID:
28660778
6.

Acrolein Can Cause Cardiovascular Disease: A Review.

Henning RJ, Johnson GT, Coyle JP, Harbison RD.

Cardiovasc Toxicol. 2017 Jul;17(3):227-236. doi: 10.1007/s12012-016-9396-5. Review.

PMID:
28084565
7.

"Pressured to prescribe" The impact of economic and regulatory factors on South-Eastern ED physicians when managing the drug seeking patient.

Kelly S, Johnson GT, Harbison RD.

J Emerg Trauma Shock. 2016 Apr-Jun;9(2):58-63. doi: 10.4103/0974-2700.179454.

8.

A novel method for deriving thresholds of toxicological concern for vaccine constituents.

White J, Wrzesinski C, Green M, Johnson GT, McCluskey JD, Abritis A, Harbison RD.

Toxicol Mech Methods. 2016 May;26(4):270-5. doi: 10.3109/15376516.2016.1170250. Epub 2016 Apr 21.

PMID:
27098016
9.

Human health risk characterization of petroleum coke calcining facility emissions.

Singh D, Johnson GT, Harbison RD.

Regul Toxicol Pharmacol. 2015 Dec;73(3):706-11. doi: 10.1016/j.yrtph.2015.10.025. Epub 2015 Nov 7.

PMID:
26520182
10.

The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity.

Coyle JP, Mayo-Perez A, Bourgeois M, Johnson G, Morris S, Harbison RD.

Int J Crit Illn Inj Sci. 2015 Jan-Mar;5(1):9-16. doi: 10.4103/2229-5151.152300.

11.

Occupational health surveillance: Pulmonary function testing in emergency responders.

McCluskey JD, Harbison SC, Johnson GT, Xu P, Morris S, Wolfson J, Harbison RD.

J Emerg Trauma Shock. 2014 Jul;7(3):180-5. doi: 10.4103/0974-2700.136861.

12.

Isocyanate and VOC exposure analysis using Flexane®.

Blake CL, Johnson GT, Abritis AJ, Lieckfield R Jr, Harbison RD.

Regul Toxicol Pharmacol. 2012 Aug;63(3):363-70. doi: 10.1016/j.yrtph.2012.05.007. Epub 2012 May 22.

PMID:
22627177
13.

Hepatoprotective effects of select water-soluble PARP inhibitors in a carbon tetrachloride model.

McCluskey JD, Sava D, Harbison SC, Muro-Cacho CA, Giffe JT, Ping X, Harbison RD.

Int J Crit Illn Inj Sci. 2011 Jul;1(2):97-103. doi: 10.4103/2229-5151.84788.

14.

Re: Evaluation of liver and thyroid toxicity in Sprague-Dawley rats after exposure to polybrominated diphenyl ether BDE-209.

Suchecka D, Banasik M, Zhu Y, Harbison RD, Biesemeier J, Stedeford T.

J Toxicol Sci. 2011 Oct;36(5):687-9; author reply 691-3. No abstract available.

15.

Airborne asbestos exposures associated with work on asbestos fire sleeve materials.

Blake CL, Harbison SC, Johnson GT, Harbison RD.

Regul Toxicol Pharmacol. 2011 Nov;61(2):236-42. doi: 10.1016/j.yrtph.2011.08.003. Epub 2011 Aug 16.

PMID:
21864629
16.

Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane.

Smith CJ, Johnson GT, Harbison RD, Zhu Y, Lee RV, Banasik M, Stedeford T.

J Occup Environ Med. 2011 Jul;53(7):707-8. doi: 10.1097/JOM.0b013e318220c30c. No abstract available.

PMID:
21738016
17.

Comment on: "Impaired oligodendroglial development by decabromodiphenyl ether in rat offspring after maternal exposure from mid-gestation through lactation".

Biesemeier JA, Banasik M, Zhu Y, Harbison RD, Smith CJ, Stedeford T.

Reprod Toxicol. 2011 Nov;32(3):372-4; author reply 375-8. doi: 10.1016/j.reprotox.2011.06.073. Epub 2011 Jun 25. No abstract available.

PMID:
21736936
18.

Comment on "Comparative tissue distribution, biotransformation and associated biological effects by decabromodiphenyl ethane and decabrominated diphenyl ether in male rats after a 90-day oral exposure study".

Banasik M, Harbison RD, Lee RV, Lassiter S, Smith CJ, Stedeford T.

Environ Sci Technol. 2011 Jun 1;45(11):5060-1; author reply 5062-3. doi: 10.1021/es200608m. Epub 2011 May 4. No abstract available.

PMID:
21542573
19.

Prenatal PBDEs and neurodevelopment: accuracy of assessment.

Goodman JE, Johnson GT, Harbison RD, Lee RV, Pulde MF, Hardy M, Stedeford T.

Environ Health Perspect. 2010 Nov;118(11):A468-9; author reply A469-70. No abstract available.

20.

Risk characterization of vapor intrusion in former manufactured gas plant sites.

DeHate RB, Johnson GT, Harbison RD.

Regul Toxicol Pharmacol. 2011 Mar;59(2):353-9. doi: 10.1016/j.yrtph.2010.12.001. Epub 2010 Dec 10.

PMID:
21146574
21.

PBDE flame retardants and thyroid hormones during pregnancy.

Goodman JE, Kerper LE, Johnson GT, Harbison RD, Cordero R, Lee RV, Pulde MF, Hardy M, Stedeford T.

Environ Health Perspect. 2010 Dec;118(12):a520; author reply a520-1. doi: 10.1289/ehp.1002782. No abstract available.

22.

Fecundability and serum PBDE concentrations in women.

Goodman JE, Biesemeier JA, Johnson GT, Harbison C, Harbison RD, Zhu Y, Lee RV, Silberberg H, Hardy M, Stedeford T.

Environ Health Perspect. 2010 Aug;118(8):a330; author reply a330-1. doi: 10.1289/ehp.1002283. No abstract available.

23.

Assessment of community healthcare providers ability and willingness to respond to emergencies resulting from bioterrorist attacks.

Crane JS, McCluskey JD, Johnson GT, Harbison RD.

J Emerg Trauma Shock. 2010 Jan;3(1):13-20. doi: 10.4103/0974-2700.55808.

24.

Comment on: Effects of decabrominated diphenyl ether (PBDE 209) exposure at different developmental periods on synaptic plasticity in the dentate gyrus of adult rats in vivo.

Johnson GT, Zhu Y, Harbison RD.

Toxicol Sci. 2010 Apr;114(2):387-8. doi: 10.1093/toxsci/kfq016. Epub 2010 Jan 25. No abstract available.

PMID:
20100737
25.

Comment on "brominated flame retardants in children's toys: concentration, composition, and children's exposure and risk assessment".

Banasik M, Hardy M, Harbison RD, Stedeford T.

Environ Sci Technol. 2010 Feb 1;44(3):1152-3; discussion 1154-6. doi: 10.1021/es903366p. No abstract available.

PMID:
20050682
26.

Characterization of cancer risk from airborne benzene exposure.

Johnson GT, Harbison SC, McCluskey JD, Harbison RD.

Regul Toxicol Pharmacol. 2009 Dec;55(3):361-6. doi: 10.1016/j.yrtph.2009.08.008. Epub 2009 Aug 22.

PMID:
19703507
27.

Dermal absorption of a dilute aqueous solution of malathion.

Scharf JE, Johnson GT, Harbison SC, McCluskey JD, Harbison RD.

J Emerg Trauma Shock. 2008 Jul;1(2):70-3. doi: 10.4103/0974-2700.43182.

28.

Tetrabromobisphenol A and model-derived risks for reproductive toxicity.

Banasik M, Hardy M, Harbison RD, Hsu CH, Stedeford T.

Toxicology. 2009 Jun 16;260(1-3):150-2; author reply 153-4. doi: 10.1016/j.tox.2009.01.026. Epub 2009 Feb 7. No abstract available.

PMID:
19464581
29.

Comment on "Elevated house dust and serum concentrations of PBDEs in California: unintended consequences of furniture flammability standards?".

Banasik M, Biesemeier J, Ariano JM, Harbison RD, Hover CG, Price DJ, Hardy M, Stedeford T.

Environ Sci Technol. 2009 Apr 1;43(7):2659-60; author reply 2661-2. No abstract available.

PMID:
19452932
30.

Occurrence of five classes of chemicals in indoor dust: an evaluation of the human health risks.

Hover C, Banasik M, Harbison RD, Hardy M, Price DJ, Stedeford T.

Sci Total Environ. 2009 Sep 1;407(18):5194-6; author reply 5197-8. doi: 10.1016/j.scitotenv.2009.04.019. Epub 2009 May 5. No abstract available.

PMID:
19419754
31.

Airborne asbestos exposure during light aircraft brake replacement.

Blake CL, Johnson GT, Harbison RD.

Regul Toxicol Pharmacol. 2009 Aug;54(3):242-6. doi: 10.1016/j.yrtph.2009.04.007. Epub 2009 May 4.

PMID:
19409949
32.

Attenuation of bromobenzene-induced hepatotoxicity by poly(ADP-ribose) polymerase inhibitors.

Hall KW, Muro-Cacho C, Abritis A, Johnson GT, Harbison RD.

Res Commun Mol Pathol Pharmacol. 2009-2010;122-123:79-95.

PMID:
25022032
33.

Attenuation of bromobenzene-induced hepatotoxicity by poly(ADP-ribose) polymerase inhibitors.

Hall KW, Muro-Cacho C, Abritis A, Johnson GT, Harbison RD.

Res Commun Mol Pathol Pharmacol. 2009-2010;122-123(1-6):79-95.

PMID:
22032092
34.

Evaluation of asbestos exposure within the automotive repair industry: a study involving removal of asbestos-containing body sealants and drive clutch replacement.

Blake CL, Dotson GS, Harbison RD.

Regul Toxicol Pharmacol. 2008 Dec;52(3):324-31. doi: 10.1016/j.yrtph.2008.09.001. Epub 2008 Sep 7.

PMID:
18809452
35.

Hepatoprotective effects of 6(5H)-phenanthridinone from chemical-induced centrilobular necrosis.

Banasik M, Stedeford T, Ueda K, Muro-Cacho C, Su PH, Tanaka S, Harbison RD.

Res Commun Mol Pathol Pharmacol. 2004;115-116:15-20.

PMID:
17564302
36.

6,(5H)-phenanthridinone protects against carbon tetrachloride-induced cytotoxicity in human HepG2 cells.

Grivas PC, Tanaka S, Ueda K, Johnson G, Harbison RD.

Res Commun Mol Pathol Pharmacol. 2007-2008;120-121(1-6):117-26.

PMID:
21469509
37.

Assessment of airborne asbestos exposure during the servicing and handling of automobile asbestos-containing gaskets.

Blake CL, Dotson GS, Harbison RD.

Regul Toxicol Pharmacol. 2006 Jul;45(2):214-22. Epub 2006 May 26.

PMID:
16730109
38.

Assessing contributory risk using economic input-output life-cycle analysis.

Miller I, Shelly M, Jonmaire P, Lee RV, Harbison RD.

Int J Environ Health Res. 2005 Apr;15(2):107-15.

PMID:
16026022
39.

Hepatocellular accumulation of poly(ADP-ribose) in male ICR mice treated with a necrogenic dose of carbon tetrachloride.

Su PH, Takehashi M, Tanaka S, Banasik M, Stedeford T, Ueda K, Muro-Cacho C, Harbison RD.

Res Commun Mol Pathol Pharmacol. 2003;113-114:171-9.

PMID:
15686116
40.

Selective inhibition of acetylcholinesterase in the cerebellum and hippocampus of mice following an acute treatment with malathion.

Banasik M, Stedeford T, Persad AS, Ueda K, Tanaka S, Muro-Cacho C, Harbison RD.

J Enzyme Inhib Med Chem. 2003 Dec;18(6):551-5.

PMID:
15008520
41.

Airborne asbestos concentration from brake changing does not exceed permissible exposure limit.

Blake CL, Van Orden DR, Banasik M, Harbison RD.

Regul Toxicol Pharmacol. 2003 Aug;38(1):58-70.

PMID:
12878055
42.

Tissue metal concentrations and histopathology of rats gavaged with vitrified soil obtained from the former Charleston Naval Shipyard (SC, USA).

Garipay RC, Muro-Cacho C, Khlifi A, Hahn G, Stedeford T, Banasik M, Harbison RD.

J Hazard Mater. 2003 Jun 27;100(1-3):1-12.

PMID:
12835008
43.

Activation of alpha(1)-adrenergic receptors potentiates the nephrotoxicity of ethylene dibromide.

Harbison RD, Stedeford T, Muro-Cacho C, Mosquera DI, Banasik M.

Toxicology. 2003 Apr 22;186(3):181-9.

PMID:
12628311
44.

Alpha1-adrenergic receptors and their significance to chemical-induced nephrotoxicity--a brief review.

Stedeford T, Cardozo-Pelaez F, Vultaggio B, Muro-Cacho C, Luzardo GE, Harbison RD.

Res Commun Mol Pathol Pharmacol. 2001 Jul-Aug;110(1-2):59-72. Review.

PMID:
12090357
45.

Comparison of base-excision repair capacity in proliferating and differentiated PC 12 cells following acute challenge with dieldrin.

Stedeford T, Cardozo-Pelaez F, Nemeth N, Song S, Harbison RD, Sanchez-Ramos J.

Free Radic Biol Med. 2001 Nov 15;31(10):1272-8.

PMID:
11705706
46.

Organ-specific differences in 8-oxoguanosine glycosylase (OGG1) repair following acute treatment with benzo[a]pyrene.

Stedeford T, Cardozo-Pelaez F, Hover C, Harbison RD, Sanchez-Ramos J.

Res Commun Mol Pathol Pharmacol. 2001 Jul;109(1-2):73-85.

PMID:
11458987
47.

Heavy metal hazards of Asian traditional remedies.

Garvey GJ, Hahn G, Lee RV, Harbison RD.

Int J Environ Health Res. 2001 Mar;11(1):63-71.

PMID:
11260788
48.

Influence of soil half-life on risk assessment of carcinogens.

Borgert CJ, Roberts SM, Harbison RD, James RC.

Regul Toxicol Pharmacol. 1995 Oct;22(2):143-51. Review.

PMID:
8577949
49.

Mechanistic studies on the potentiation of carbon tetrachloride hepatotoxicity by methamphetamine.

Roberts SM, Harbison RD, James RC.

Toxicology. 1995 Mar 31;97(1-3):49-57.

PMID:
7716792
50.

Exacerbation of carbon tetrachloride-induced liver injury in the rat by methamphetamine.

Roberts SM, Harbison RD, Westhouse RA, James RC.

Toxicol Lett. 1995 Feb;76(1):77-83.

PMID:
7701520

Supplemental Content

Loading ...
Support Center